Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Periodization-Based Strength Exercise Training in İndividuals With Type 2 Diabetes

NCT07659925 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-05-01
Last updated
2026-06-22

Condition(s) studied

Type 2 Diabetes

Investigational drug(s) / intervention(s)

Non-linear Periodization-Based Strength TrainingLinear Periodization-Based Strength TrainingUsual Care

Non-linear Periodization-Based Strength Training: Participants will perform supervised non-linear periodization-based strength training three times per week for 8 weeks.

Linear Periodization-Based Strength Training: Participants will perform supervised linear periodization-based strength training three times per week for 8 weeks.

Usual Care: Participants will receive usual care and no structured exercise intervention during the study period.

Study summary

This randomized controlled study aims to compare the effects of different periodization-based strength training approaches in individuals with type 2 diabetes mellitus. Participants will be allocated to non-linear periodization, linear periodization, or control groups. The intervention program will be conducted for 8 weeks and will evaluate exercise capacity, muscle strength, quality of life, body composition, and metabolic parameters.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged between 18 to 65 years * Diagnosis of Type 2 Diabetes Mellitus (T2DM) * Not having participated in any structured exercise program within the last 6 months * Willingness to participate in the study and provide written informed consent Exclusion Criteria: * Presence of nephropathy, retinopathy, or peripheral neuropathy * Presence of neurological, cognitive, or orthopedic disorders that may affect outcome measurements * Severe respiratory disease (Forced Expiratory Volume in the first second \[FEV1\] \<35% or Forced Vital Capacity \[FVC\] \<50%) * Presence of ischemic heart disease or peripheral arterial disease * History of any cardiovascular event within the last 6 months * Current malignancy

Primary outcome measure(s)

  • Exercise Capacity — Baseline and after 8 week
    Exercise capacity will be assessed using the 6-Minute Walk Test (6MWT)

Trial sites (1)

FacilityCityRegionStatus
Baskent University Hospital Ankara Ankara Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07659925 on ClinicalTrials.gov ↗ ← All trials in Turkey